Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001159036-14-000083)

Filing Details

Accession Number:: 0001159036-14-000083
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-09-16 18:44:57
Reporting Period:: 2014-09-16

Filing Date:: 2014-09-16
Accepted Time:: 2014-09-16 18:44:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1159036	Halozyme Therapeutics Inc	HALO	Biological Products, (No Disgnostic Substances) (2836)	880488686

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1283292	A David Ramsay	11388 Sorrento Valley Road San Diego CA 92121	Vp And Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-09-16	50,000	$2.05	298,492	No	4	M	Direct
Common Stock	Acquisiton	2014-09-16	25,000	$8.90	323,492	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option to Purchase Common Stock	Disposition	2014-09-16	50,000	$2.05	50,000	$2.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2009-02-01	2014-10-13	No	4	M	Direct

Footnotes

This transaction was executed in multiple purchases at prices ranging from $8.83 to $9.01. The price reported in this column reflects the weighted average purchase price. The Reporting Person will provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.